148 related articles for article (PubMed ID: 37610648)
21. Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.
Little SE; Popov S; Jury A; Bax DA; Doey L; Al-Sarraj S; Jurgensmeier JM; Jones C
Cancer Res; 2012 Apr; 72(7):1614-20. PubMed ID: 22311673
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
[TBL] [Abstract][Full Text] [Related]
23. The role of
Dono A; Ramesh AV; Wang E; Shah M; Tandon N; Ballester LY; Esquenazi Y
Neurooncol Adv; 2021; 3(1):vdab050. PubMed ID: 34131647
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Otsuji R; Hamada T; Matsuo K; Kirishima M; Hata N; Hanaya R; Tanimoto A; Yoshimoto K
Neurooncol Adv; 2022; 4(1):vdac097. PubMed ID: 35911637
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.
Alentorn A; Marie Y; Carpentier C; Boisselier B; Giry M; Labussière M; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2012 Nov; 14(11):1393-403. PubMed ID: 23074200
[TBL] [Abstract][Full Text] [Related]
26. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.
McIntyre A; Summersgill B; Grygalewicz B; Gillis AJ; Stoop J; van Gurp RJ; Dennis N; Fisher C; Huddart R; Cooper C; Clark J; Oosterhuis JW; Looijenga LH; Shipley J
Cancer Res; 2005 Sep; 65(18):8085-9. PubMed ID: 16166280
[TBL] [Abstract][Full Text] [Related]
27. Predictive and prognostic value of phosphorylated c-KIT and PDGFRA in advanced non-small cell lung cancer harboring ALK fusion.
Yang H; Wang F; Deng Q; Xiao D; He P; Lin X; He D
Oncol Lett; 2019 Mar; 17(3):3071-3076. PubMed ID: 30867736
[TBL] [Abstract][Full Text] [Related]
28. Copy Number Profiling of Brazilian Astrocytomas.
Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
[TBL] [Abstract][Full Text] [Related]
29. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
[TBL] [Abstract][Full Text] [Related]
30. Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
Trevisan P; Graziadio C; Rodrigues DBK; Rosa RFM; Soares FP; Provenzi VO; de Oliveira CAV; Paskulin GA; Varella-Garcia M; Zen PRG
J Neuropathol Exp Neurol; 2019 Apr; 78(4):297-304. PubMed ID: 30840759
[TBL] [Abstract][Full Text] [Related]
31. Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.
Shepherd DJ; Miller TE; Forst DA; Jones P; Nardi V; Martinez-Lage M; Stemmer-Rachamimov A; Gonzalez RG; Iafrate AJ; Ritterhouse LL
Oncologist; 2021 Nov; 26(11):919-924. PubMed ID: 34041811
[TBL] [Abstract][Full Text] [Related]
32. Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.
Cao D; Antonescu C; Wong G; Winter J; Maitra A; Adsay NV; Klimstra DS; Hruban RH
Mod Pathol; 2006 Sep; 19(9):1157-63. PubMed ID: 16778826
[TBL] [Abstract][Full Text] [Related]
33. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.
Lassus H; Sihto H; Leminen A; Nordling S; Joensuu H; Nupponen NN; Butzow R
Br J Cancer; 2004 Dec; 91(12):2048-55. PubMed ID: 15583695
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
37. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
39. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
Holtkamp N; Okuducu AF; Mucha J; Afanasieva A; Hartmann C; Atallah I; Estevez-Schwarz L; Mawrin C; Friedrich RE; Mautner VF; von Deimling A
Carcinogenesis; 2006 Mar; 27(3):664-71. PubMed ID: 16357008
[TBL] [Abstract][Full Text] [Related]
40. Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes.
Kumar A; Boyle EA; Tokita M; Mikheev AM; Sanger MC; Girard E; Silber JR; Gonzalez-Cuyar LF; Hiatt JB; Adey A; Lee C; Kitzman JO; Born DE; Silbergeld DL; Olson JM; Rostomily RC; Shendure J
Genome Biol; 2014 Dec; 15(12):530. PubMed ID: 25608559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
